Author's Reply to Peronard and Mayntz: "SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect".

{"title":"Author's Reply to Peronard and Mayntz: \"SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect\".","authors":"David Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera-Martínez, David Corredor-Rengifo, Jorge Rico-Fontalvo, Juan Esteban Gómez-Mesa, John Jairo Duque-Ossman, Alin Abreu-Lomba","doi":"10.1007/s40256-024-00707-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7652,"journal":{"name":"American Journal of Cardiovascular Drugs","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Cardiovascular Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40256-024-00707-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}